BICARA THERAPEUTICS INC (BCAX) Stock Analyst Earnings Estimates
NASDAQ:BCAX - Nasdaq - US0554771032 - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||
| EBITDA YoY % growth | -37.646M | -39.87M -5.91% | N/A -92.03% | N/A -30.10% | N/A -31.46% | |
| EBIT YoY % growth | -37.656M | -39.889M -5.93% | N/A -98.74% | N/A -33.78% | N/A -31.83% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 33.87% | N/A -29.02% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 | -0.37 | -0.40 | -0.42 73.50% | -0.49 -47.17% | -0.46 -25.69% | -0.48 -21.13% | -0.50 -17.14% | -0.51 -5.25% |
| Revenue Q2Q % growth | |||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -22.636M 43.25% | -22.879M | -23.993M 31.69% | -25.436M -23.31% | -28.543M -26.10% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.60 | -0.47 | -1.13 | -241.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.49% | 1.39% | -0.04% | 8.54% |
| Revenue | N/A | N/A | N/A | N/A |